Cti BioPharma
(NASDAQ) CTIC
Cti BioPharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$75.77M
Net Income (TTM)
$77.01M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CTIC News
CTIC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cti BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
128
CEO
Adam R. Craig, MD, PhD
Website
www.ctibiopharma.comHeadquarters
Seattle, WA 98121, US
CTIC Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-1%
Net Income Margin
-2%
Return on Equity
13%
Return on Capital
-2%
Return on Assets
-72%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$50.43M
Operating Income
$79.80M
EBITDA
$79.85M
Operating Cash Flow
$81.19M
Capital Expenditure
$25.00M
Free Cash Flow
$106.19M
Cash & ST Invst.
$79.94M
Total Debt
$49.96M
Cti BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.12M
+950.8%
Gross Profit
$22.89M
+1035.0%
Gross Margin
94.92%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
127
N/A
Net Income
$21.80M
+41.4%
EBITDA
$7.85M
+77.4%
Quarterly Fundamentals
Net Cash
$10.12M
-79.2%
Accounts Receivable
$22.96M
+846.3%
Inventory
$777.00K
+661.8%
Long Term Debt
$0.00
N/A
Short Term Debt
$48.08M
-0.5%
Return on Assets
-72.30%
N/A
Return on Invested Capital
-1.78%
N/A
Free Cash Flow
$31.10M
-3.7%
Operating Cash Flow
$31.10M
-3.7%